Presence of extended-spectrum beta-lactamase–producing Escherichia coli in fecal content of cattle from two slaughterhouses in Lima, Peru, 2023–2024
Descripción del Articulo
The indiscriminate use of antimicrobials has led enterobacteria such as Escherichia coli to develop a variety of resistance mechanisms such as the production of extended-spectrum beta-lactamases (ESBL). Beta-lactam antimicrobials including penicillins, monobactams, and cephalosporins are among the m...
| Autores: | , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2024 |
| Institución: | Universidad Peruana Cayetano Heredia |
| Repositorio: | Revistas - Universidad Peruana Cayetano Heredia |
| Lenguaje: | español |
| OAI Identifier: | oai:revistas.upch.edu.pe:article/6867 |
| Enlace del recurso: | https://revistas.upch.edu.pe/index.php/STV/article/view/6867 |
| Nivel de acceso: | acceso abierto |
| Sumario: | The indiscriminate use of antimicrobials has led enterobacteria such as Escherichia coli to develop a variety of resistance mechanisms such as the production of extended-spectrum beta-lactamases (ESBL). Beta-lactam antimicrobials including penicillins, monobactams, and cephalosporins are among the most widely used in both animals and humans; Therefore, the presence of ESBL-producing E. coli (ESBL-EC) has the ability to hydrolyze these antimicrobials, leading to resistance against this class of agents, which represents a potencial threat to human and animal health. This study aimed to determine the presence of ESBL-EC in fecal samples from cattle at two slaughterhouses in Lima, Peru. A total of 260 fecal samples from cattle were collected at two slaughterhouses: S1 (n=134) and S2 (n=126). Antibiotic discs of cefotaxime (CTX) 30 µg, aztreonam (ATM) 30 µg, ceftazidime (CAZ) 30 µg, cefpodoxime (CPD) 10 µg and ceftriaxone (CRO) were used as screening method. While, antimicrobials cefotaxime - clavulanic acid (CTX-CLA) (30/10 µg) and ceftazidime - clavulanic acid (CAZ-CLA) (30/10 µg) were used in combined disc method for ESBL-EC phenotypic confirmation. The interpretation results follow the guidelines of the Clinical and Laboratory Standards Institute (CLSI). Finally, was determined that 23.5% (61/260) of fecal sample presented ESBL-EC. Our results demonstrate that cattle intended for human consumption are carriers of ESBL-EC representing a potential public health risk. Keywords: ESBL-EC, antimicrobial resistance, cattle |
|---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).